VCM
BLTE

Voleon Capital Management’s Belite Bio BLTE Stock Holding History

Voleon Capital Management’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$968K Sell
6,289
-1,594
-20% -$244K 0.02% 478
2026
Q1 		$1.26M Buy
+7,883
New +$1.33M 0.03% 402

Other funds holding BLTE

DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Voleon Capital Management's BLTE Position: Q2 2026 in Review

Voleon Capital Management reduced its Belite Bio (BLTE) stake by 20% in Q2 2026, selling an estimated $244K and leaving 6,289 shares worth $968K. The position accounts for 0.02% of the portfolio, ranked #478.

Voleon Capital Management first reported a position in BLTE in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.26M in Q1 2026. 80 funds tracked by Wall St. Rank hold BLTE as of Q2 2026.

  • Voleon Capital Management held 6,289 shares of Belite Bio worth $968K as of Q2 2026.
  • Voleon Capital Management sold 1,594 Belite Bio shares in Q2 2026, an estimated $244K.
  • Belite Bio made up 0.02% of Voleon Capital Management's portfolio in Q2 2026, its #478 holding.
  • Voleon Capital Management first reported a position in Belite Bio in Q1 2026 and has held it in 2 quarters since.
  • Voleon Capital Management's Belite Bio position peaked at $1.26M in Q1 2026.
  • 80 funds tracked by Wall St. Rank held Belite Bio as of Q2 2026.

Based on Voleon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.